← Back to Search

Telephone-Based Exercise for Colorectal and Breast Cancer (AACT Trial)

N/A
Waitlist Available
Led By Jennifer Ligibel, MD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Histologically confirmed stage I-III breast or colorectal cancer
No major surgery within 2 months of study enrollment or planned during study period
Must not have
Metastatic cancer
Plans to have hip or knee replacement within a year
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether cancer survivors who receive phone calls from an exercise specialist are more likely to increase their physical activity.

Who is the study for?
The AACT is for adults over 18 who've had stage I-III breast or colorectal cancer and finished their main treatments, except certain ongoing therapies for breast cancer. They should be medically cleared for unsupervised exercise, speak English, and not be very active currently. Those with serious health issues, metastatic cancer, upcoming major surgeries or extremely high BMI are excluded.
What is being tested?
This trial tests if a phone-based counseling program can boost physical activity in people who have completed chemotherapy for breast or colorectal cancer. It involves talking to an exercise specialist regularly to see if it helps increase exercise levels and improve mood, fatigue, fitness, body fat distribution and weight.
What are the potential side effects?
Since the intervention is non-medical (exercise advice via telephone), there are no direct side effects like you'd expect from drugs; however participants may experience typical exercise-related discomforts such as muscle soreness or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My cancer is in the early to mid-stages and confirmed by tissue analysis.
Select...
I haven't had major surgery in the last 2 months and don't plan any soon.
Select...
I am 18 years old or older.
Select...
I have finished all additional treatments for my current cancer.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My cancer has spread to other parts of my body.
Select...
I plan to have a hip or knee replacement within the next year.
Select...
I do not have any severe illnesses like heart failure or mental health issues that would stop me from following the study's requirements.
Select...
My BMI is over 47.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 1Experimental Treatment1 Intervention
Immediate participation in a 16-week exercise program
Group II: 2Active Control1 Intervention
Control population; will receive exercise plan after 16-week control period

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,108 Previous Clinical Trials
357,117 Total Patients Enrolled
Cancer and Leukemia Group BNETWORK
80 Previous Clinical Trials
117,868 Total Patients Enrolled
Jennifer Ligibel, MDPrincipal InvestigatorDana-Farber Cancer Institute
9 Previous Clinical Trials
3,846 Total Patients Enrolled

Media Library

Telephone-Based exercise intervention Clinical Trial Eligibility Overview. Trial Name: NCT00548236 — N/A
Colorectal Cancer Research Study Groups: 2, 1
Colorectal Cancer Clinical Trial 2023: Telephone-Based exercise intervention Highlights & Side Effects. Trial Name: NCT00548236 — N/A
Telephone-Based exercise intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT00548236 — N/A
~7 spots leftby Nov 2025